Pfizer ( PFE) ($25.43): Releases their earnings report pre-market on Tuesday. The stock has a buy rating according to ValuEngine with a favorable P/E. The stock is above its 200-day simple moving average (SMA) at $22.91. Pfizer set a multi-year high at $26.09 on Oct. 18. The weekly chart is overbought with the five-week modified moving average (MMA) at 24.91 and the 200-week SMA at $18.54. Investors and traders should sell strength to my quarterly pivot at $25.74 and then employ a "buy-and-trade" strategy between the value level and risky level.

MasterCard ( MA) ($452.98): Releases its earnings report pre-market on Wednesday. The stock has a buy rating according to ValuEngine with an elevated P/E and is above its 200-day SMA at $424.28. The stock set a multi-year high at $486.08 on Oct. 17. The weekly chart profile is negative with the 200-week SMA at $278.04. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Stocks Reporting Pre-market Thursday

Barrick Gold ( ABX) ($39.18): Has a buy rating according to ValuEngine with a favorable P/E. The stock is below its 200-day SMA at $40.69. The stock set its 2012 high at $50.39 on Feb. 2 and its 2012 low at $31.00 on July 26. The weekly chart profile is negative with the 200-week SMA at $42.42. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Teva Pharmaceuticals ( TEVA) ($40.39): Has a buy rating according to ValuEngine with a favorable P/E and is below its 200-day SMA at $41.94. The stock set its 2012 high at $46.38 on May 1 and its 2012 low at $37.40 on June 20. The weekly chart is neutral with the stock below its 200-week SMA at $47.96. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Exxon Mobile ( XOM) ($90.62): Has a buy rating according to ValuEngine with a reasonable P/E and is above its 200-day SMA at $86.24. The stock set a multi-year high at $93.67 on Oct. 19. The weekly chart is overbought and shifts to negative with a weekly close below the five-week MMA at $90.70. The 200-week SMA is at $74.98. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

If you liked this article you might like

Energy Takes a Backseat as Crude Oil Stabilizes Under $50

Exxon's Beaumont, Texas Refinery Could Restart Most Operations This Week

Here's Where Wall Street Stands

11 Stock Picks for the Coming Oil Breakout

Dow Posts Fresh Record, Third in a Row, but S&P 500 and Nasdaq Fall